Qpex Biopharma, Inc., a biopharmaceutical company dedicated to anti-infective therapies, has entered into a multi-product collaboration in China with Brii Biosciences to develop and commercialize Qpex’s portfolio of potentially best-in-class therapies to treat a range of multi-drug resistant gram-negative infections. “We are thrilled to be working together with a team that shares our vision and dedication to address the global antimicrobial resistance problem,” said Michael ...